Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
GlobeNewswire
MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology..
MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology..
Initiates Strategic Repositioning to Focus on Company’s Core RNA Delivery TechnologyAltamira Therapeutics retains 49% in Altamira..
HAMILTON, BERMUDA , Sept. 14, 2023 (GLOBE NEWSWIRE) --
--------------------
· *Fresh data from..